På rotter blev det vist, at sorafenib og dens metabolitter passerer placenta og sorafenib forventes at skade fostret.
In rats, sorafenib and its metabolites were demonstrated to cross the placenta and sorafenib is anticipated to cause harmful effects on the foetus.